Oramed Pharm's market cap is currently ―. The company's EPS TTM is $0.136; its P/E ratio is 17.73; Oramed Pharm is scheduled to report earnings on July 10, 2024, and the estimated EPS forecast is $0.02. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	-	-	$ 674.00K	$ 666.00K	-
Gross Profit	-	-	$ 674.00K	$ 666.00K	-
EBIT	$ 18.58M	$ -2.46M	$ -3.79M	$ 6.54M	-
EBITDA	$ 18.64M	-	$ -3.74M	$ 6.58M	-
Net Income Common Stockholders	$ 13.34M	$ -3.22M	$ -1.19M	$ 8.35M	-
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 66.77M	$ 5.47M	$ 7.71M	$ 153.73M	$ 155.72M
Total Assets	$ 220.55M	$ 230.89M	$ 156.31M	$ 158.78M	$ 161.64M
Total Debt	$ 51.95M	$ 76.00M	$ 727.00K	$ 807.00K	$ 895.00K
Net Debt	$ -14.82M	$ 70.53M	$ -6.98M	$ -152.93M	$ -154.82M
Total Liabilities	$ 57.66M	$ 82.66M	$ 5.66M	$ 9.60M	$ 10.49M
Stockholders Equity	$ 163.82M	$ 149.13M	$ 151.55M	$ 150.97M	$ 151.81M
Cash Flow	-
Free Cash Flow	$ -1.42M	-	$ -2.65M	$ -5.75M	$ -8.35M
Operating Cash Flow	$ -1.42M	$ -694.00K	$ -2.63M	$ -5.55M	$ -8.06M
Investing Cash Flow	$ 30.00M	$ -75.12M	$ -14.71M	$ -13.20M	$ 11.26M
Financing Cash Flow	$ -25.00M	$ 74.55M	-	$ 2.43M	$ 4.17M

Currency in USD

Oramed Pharm Earnings and Revenue History

Income Statement >

Oramed Pharm Debt to Assets

Balance Sheet >

Oramed Pharm Cash Flow

Cash Flow >

Oramed Pharm Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing